Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim's Emerging Outlook: Biotech Summit GlobeNewswire February 04, 2026 LOS ALTOS, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced that Shalabh Gupta, M.D., Chief Executive […]

Zenas BioPharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 GlobeNewswire February 04, 2026 WALTHAM, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with

NEW YORK CITY, NY / ACCESS Newswire / February 4, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Richtech Robotics Inc. (NASDAQ:RR) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the

NEW YORK CITY, NY / ACCESS Newswire / February 4, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Picard Medical, Inc. (NYSE:PMI) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the

NEW YORK CITY, NY / ACCESS Newswire / February 4, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Plug Power Inc. ("Plug Power" or the "Company") (NASDAQ:PLUG) and certain officers.�� The class action, filed in the United States District Court for the Northern District of New York, and docketed

NEW YORK CITY, NY / ACCESS Newswire / February 4, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against China Liberal Education Holdings Ltd. (OTCMKTS:CLEUF) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations

NEW YORK CITY, NY / ACCESS Newswire / February 4, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Vistagen Therapeutics, Inc. ("Vistagen" or the "Company") (NASDAQ:VTGN).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

NEW YORK CITY, NY / ACCESS Newswire / February 4, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Beyond Meat, Inc. (NASDAQ:BYND) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the

NEW YORK CITY, NY / ACCESS Newswire / February 4, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Endeavor Group Holdings, Inc. (NYSE:EDR) certain of Endeavor’s directors, Silver Lake Group, L.L.C. ("Silver Lake") and certain of its affiliates (collectively, "Defendants").

NEW YORK CITY, NY / ACCESS Newswire / February 4, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Vistagen Therapeutics, Inc. (NASDAQ:VTGN) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the